Table 3A. Grade 3 and 4 toxicities attributed to aflibercept and temozolomide for Arm 1.
Adverse Event | Aflibercept DL0 | Aflibercept DL1 | Temozolomide (DL0) | Temozolomide (DL1) |
---|---|---|---|---|
Abdominal pain | 1 | |||
Alanine aminotransferase increase | 1 | |||
Aspartate aminotransferase increase | 1 | |||
Alkaline phosphatase increase | 1 | |||
Bilirubin increase | 2 | 1 | ||
Gamma glutamyl transferase increase | 1 | |||
Arthralgia | 1 | 1 | ||
Colonic perforation | 1 | |||
Colitis | 1 | |||
Dehydration | 1 | |||
Fatigue | 1 | 1 | ||
Headache | 1 | |||
Hypertension | 1 | |||
Hypokalemia | 1 | |||
Hyponatremia | 1 | |||
Seizure | 3 | 3 | ||
Nausea | 1 | |||
Lung infection | 1 | |||
Peripheral nerve infection | 1 | |||
Urinary tract infection | 1 | |||
Vascular access complication | 1 | 1 | ||
Leukopenia | 1 | 1 | ||
Lymphopenia | 3 | 4 | ||
Neutropenia | 2 | 2 | ||
Thrombocytopenia | 2 | 2 | ||
Investigations (other) | 1 |